Literature DB >> 25443720

Rupatadine effectively prevents the histamine-induced up regulation of histamine H1R and bradykinin B2R receptor gene expression in the rat paw.

Dimitra Molyva1, Konstantinos Kalokasidis2, Christos Poulios3, Hara Dedi4, George Karkavelas5, Vassiliki Mirtsou6, Antonis Goulas7.   

Abstract

BACKGROUND: Activation of histamine H1 receptor (H1R) is a well-known hallmark of allergic and inflammatory pathology. Both types of bradykinin receptors (B1R and B2R) are also known to contribute significantly to the latter and some sort of functional interaction between them and H1R has been alluded to in the past. Here we use an experimental model of rat paw oedema formation to examine the effect of exogenously added histamine on the gene expression of H1R and bradykinin receptors B1R and B2R, alone or in combination to rupatadine, a second generation antihistamine agent.
METHODS: Histamine-induced oedema formation was monitored with a plethysmometer. The gene expression of H1R, B1R and B2R was analyzed with both conventional and real-time PCR. Rupatadine fumarate was used in pure form and administered intraperitoneally, prior to histamine injection into the paw. Microscopy of haematoxylin and eosin-stained sections of paw tissue was used to examine effects on tissue architecture.
RESULTS: Histamine injection into the paw resulted in significant up regulation of H1R and B2R without inducing significant cellular infiltration, but appears to affect less the expression of B1R. Rupatadine was, under the conditions used in this study, very effective in preventing this effect and in suppressing oedema formation through its antihistamine action.
CONCLUSION: Rupatadine has a suppressing effect on H1R and B2R gene expression which could add to its efficacy towards allergy and allergy-like conditions.
Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Bradykinin receptors; Gene expression; Histamine H1 receptor; Rat paw; Rupatadine

Mesh:

Substances:

Year:  2014        PMID: 25443720     DOI: 10.1016/j.pharep.2014.06.008

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  5 in total

Review 1.  Neuroendocrinology of the skin.

Authors:  Theoharis C Theoharides; Julia M Stewart; Alexandra Taracanova; Pio Conti; Christos C Zouboulis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

Review 2.  Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin.

Authors:  Theoharis C Theoharides; Julia M Stewart; Erifili Hatziagelaki; Gerasimos Kolaitis
Journal:  Front Neurosci       Date:  2015-07-03       Impact factor: 4.677

3.  LASSBio-1586, an N-acylhydrazone derivative, attenuates nociceptive behavior and the inflammatory response in mice.

Authors:  Juliane Cabral Silva; Raimundo Gonçalves de Oliveira Júnior; Mariana Gama E Silva; Érica Martins de Lavor; Juliana Mikaelly Dias Soares; Sarah Raquel Gomes de Lima-Saraiva; Tâmara Coimbra Diniz; Rosemairy Luciane Mendes; Edilson Beserra de Alencar Filho; Eliezer Jesus de Lacerda Barreiro; Lídia Moreira Lima; Jackson Roberto Guedes da Silva Almeida
Journal:  PLoS One       Date:  2018-07-30       Impact factor: 3.240

4.  Antinociceptive and anti-inflammatory effects of hydrazone derivatives and their possible mechanism of action in mice.

Authors:  Maria Alice Miranda Bezerra Medeiros; Mariana Gama E Silva; Jackson de Menezes Barbosa; Érica Martins de Lavor; Tiago Feitosa Ribeiro; Cícero André Ferreira Macedo; Luiz Antonio Miranda de Souza Duarte-Filho; Thiala Alves Feitosa; Jussara de Jesus Silva; Harold Hilarion Fokoue; Cleônia Roberta Melo Araújo; Arlan de Assis Gonsalves; Luciano Augusto de Araújo Ribeiro; Jackson Roberto Guedes da Silva Almeida
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

Review 5.  Genitourinary mast cells and survival.

Authors:  Theoharis C Theoharides; Julia M Stewart
Journal:  Transl Androl Urol       Date:  2015-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.